![U.S. Embassy in South Sudan](https://www.africa-newsroom.com/files/large/c8e1372a80256f0)
On September 1, the U.S. Embassy delivered 96 kits of mpox reagents to the South Sudan National Public Health Laboratory to ensure rapid testing of suspected mpox cases in South Sudan. The kits were provided by the U.S. Centers for Disease Control and Prevention (CDC). Additionally, the U.S Embassy in Juba will continue to provide technical assistance on preparing for and responding to a potential mpox outbreak in South Sudan. This includes CDC support for building local capacity in disease surveillance through the South Sudan Field Epidemiology Training Program, which has trained 177 skilled field epidemiologists at all levels of South Sudan’s health system. The expertise of those field epidemiologists is currently used to support Ministry of Health efforts for a timely and responsive disease surveillance system in South Sudan.
The United States will continue its support of life-saving medical care for the South Sudanese people. At the same time, we call on the transitional government to increase its use of public revenue to support the health sector.
Distributed by APO Group on behalf of U.S. Embassy in South Sudan.
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
© ZAWYA 2024